Skip to content

Clinical trials

Phase 1 Choroidal Neovascularization trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Phase: Phase 1 Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20041
20053
20063
20074
20081
20091
20103
20121
20131
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)5
GlaxoSmithKline3
Johns Hopkins University2
Alcon Research1
Clement K. Chan1
Graybug Vision1
Hawaii Pacific Health1
Light Sciences LLC1
Novartis Pharmaceuticals1
Ophthalmic Consultants of Boston1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization24
Macular Degeneration16
Diabetic Retinopathy3
Geographic Atrophy2
Inflammation2
Macular Edema2
Retinal Vein Occlusion2
Uveitis2
Angioid Streaks1
Eye Diseases1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.